NASH - NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sleeve surgery vs. diet: which tames NASH better?
Disease control Recruiting nowThis study tests whether adding weight-loss surgery (vertical sleeve gastrectomy) to lifestyle changes is more effective than lifestyle changes alone for people with NASH, a serious liver condition. About 48 adults aged 30-70 with NASH and obesity will be randomly assigned to one…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
New drug could slow liver scarring in NASH cirrhosis patients
Disease control Recruiting nowThis study tests a drug called efruxifermin in about 2,150 adults with liver cirrhosis (severe scarring) caused by NASH/MASH, a type of fatty liver disease. Participants will receive either the drug or a placebo to see if it can prevent serious liver events and improve fibrosis. …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
Surgery may beat drugs for fatty liver in obese patients
Disease control Recruiting nowThis study tests if bariatric (weight-loss) surgery is more effective than standard medical treatment at making nonalcoholic steatohepatitis (NASH) disappear without worsening liver scarring. It involves 100 obese adults with advanced liver fibrosis. Participants are randomly ass…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
Needle-Free NASH diagnosis: new MRI test could spare patients painful biopsies
Diagnosis Recruiting nowThis study is testing whether a special MRI scan (called cT1) can accurately diagnose NASH, a serious liver disease, without needing a painful needle biopsy. About 225 adults who are already scheduled for a liver biopsy will get the scan first. If the scan works well, it could be…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: Perspectum • Aim: Diagnosis
Last updated May 26, 2026 03:14 UTC
-
Scientists probe hidden link between belly fat and liver damage
Knowledge-focused Recruiting nowThis study looks at how inflammation in fat tissue is connected to fat buildup in the liver and insulin resistance in people with severe obesity. Researchers will measure liver stiffness and markers of inflammation in 60 adults who are having gastric bypass surgery. The goal is t…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC